Breaking News, Promotions & Moves

Sagent Seeks New CEO

Yordon retires, Kung to serve as chairman

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Jeffrey Yordon, chairman and chief executive officer, will retire from Sagent Pharmaceuticals, Inc. and will remain a member of the board. Frank Kung, Ph.D., a member of Sagent’s Board since 2006, has been named chairman. The company has begun a search for a new CEO. In the interim, an executive management committee has been appointed to lead the company. Additionally, James Hussey, who served as the company’s president, has decided to leave the company. Mr. Kung said, “On ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters